scispace - formally typeset
K

Karin M Danzer

Researcher at University of Ulm

Publications -  73
Citations -  6258

Karin M Danzer is an academic researcher from University of Ulm. The author has contributed to research in topics: Alpha-synuclein & Amyotrophic lateral sclerosis. The author has an hindex of 31, co-authored 65 publications receiving 5168 citations. Previous affiliations of Karin M Danzer include German Center for Neurodegenerative Diseases & Harvard University.

Papers
More filters
Journal ArticleDOI

Exosomal cell-to-cell transmission of alpha synuclein oligomers

TL;DR: The data suggest that αsyn may be secreted via different secretory pathways, and hypothesize that exosome-mediated release of αsyn oligomers is a mechanism whereby cells clear toxic α synuclein oligomers when autophagic mechanisms fail to be sufficient.
Journal ArticleDOI

Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding

TL;DR: The data indicate that inhibition of early α- syn aggregation events would consequently prevent all α-syn oligomer related toxicities, which has important implications for the development of disease-modifying drugs for the treatment of PD and other synucleinopathies.
Journal ArticleDOI

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies

TL;DR: CSF exosomes of patients with Parkinson’s disease or dementia with Lewy bodies contain α- synuclein and induce α-synuclein aggregation in a reporter cell line, indicating that exosome support may support inter-neuronal transmission of α- Synuclein pathology.
Journal ArticleDOI

Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity

TL;DR: In a cellular model, the presence of αsyn oligomers in the extracellular space, their uptake by neurons, retrograde axonal transport to cell soma, and detrimental effects on neighboring cells are demonstrated and their modulation by Hsp70 represents a potential new target for therapeutic interventions.